Shareholding disclosure

Santhera Pharmaceuticals Holding AG

Collectively declared rate

15.53%

Threshold

Crossed upwards

Timeline

Published

20.05.2009

Transaction

14.05.2009

Transfer date

15.05.2009

Voting rights breakdown

Voting rights acquired15.53%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 3

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TB95J00014

Beneficial owner

Ernesto Bertarelli

Declared address

Ernesto Bertarelli, 3780 Gstaad

Direct acquirer acts on behalf of Ares Life Sciences GP Ltd ("Ares"), at the same address as the direct acquirer ("Omega"). Ares is held by the beneficial owners through Kedge Capital Holdings (Jersey) Limited, at the same address as Omega. Omega is held by the beneficial owners through (i) the Landmark Limited Parternship, a limited partnership having its registered office at the same address as Omega and (ii) Bertarelli SCA, a partnership limited by shares having its registered office at 412, route d'Esch, L-1030 Luxembourg

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open